Søren Skjold Mogensen Email & Phone Number

Copenhagen, Dk

Copenhagen

Member of Senior Leadership Team and reporting to CEO.

Copenhagen, Capital Region, Denmark

Hillerød, Capital Region, Denmark

CEO of SSI Diagnostica Holding A/S - includes SSI Diagnostica A/S and CTK Biotech, Inc.

Copenhagen Area, Capital Region, Denmark

- Global commercial responsible (Sales, Marketing, Business Development) - Member in Corporate Management team.- Building and expanding SSI Diagnostica A/S global sales performance. - Expanding the base of very motivated, highly skilled and very passionate colleagues. SSI Diagnostica A/S is a very well positioned diagnostic company with high quality products targeting microbiology laboratories (hospital & industry), life science industry and general practise doctors.

Copenhagen Area, Denmark

RESPONSIBILITIES: - Regional Vice President responsible for region: Russia, CIS countries, Belarus, Slovakia, Croatia, Serbia, Slovenia, Malta and the Baltics. Reporting to SVP Joao Carlos Rocha.- Optimise current and new products sales and profits. -140 FTE in total team, affiliate offices and country managers directly reporting (excl. distributor in CIS, Belarus and Malta)RESULTS: - Analysis, define and implement new Go to market strategy for new product launches, including adjustments in organizational setup. - Sign and implement co-promotion agreement with R Pharm in Russia. - High sales and profits of Cipralex and Lundbeck mature products. - Launch Brintellix, Abilify Maintena, Selincro. Brintellix in the top 3 of global Brintellix launches, with 0,70 vol. MS% 3 months after launch.

Panama City, Panama

RESPONSIBILITIES- General Manager and responsible for establishing New Region in Lundbeck. Countries: Costa Rica, Panama, Guatemala, Dominican Republic, Nicaragua, el Salvador, Honduras, Caribbean (Jamaica, Curacao, Aruba), Equador. 11 markets with 82 million inhabitants. Reporting to RVP Alberto Weder.- Build up new markets; relaunch current products and prepare for launch of new products. - 27 FTE in total team. Regional office in Panama City. RESULTS- Established successfully Lundbeck America Central SA, from nothing to a high performing company increasing sales and profits and getting ready for new product launches. - Analysis, define and implement optimal market by market distributor setup and sales channels. - Established a low cost and flexible warehouse and supply chain setup with base in Colon Free Zone with Colon Import & Export SA. - Strong increase in market shares, sales and profits of Lexapro/Cipralex and mature products. - Employee satisfaction survey (ESS 2013) showed that Lundbeck America Central employees reported index 89 for satisfaction and motivation. Same measure was 82 for Latin America as a group and 74 for H. Lundbeck A/S globally.

Copenhagen Area, Capital Region, Denmark

RESPONSIBLE- Head of Global Strategic Marketing Established and New Products. Reporting to EVP Stig Løkke Pedersen. - Develop go to market strategies and launch plans for Lundbeck new products (Brintellix (Major Depression), Selincro (Alcohol reduction), Desmoteplase (Ischemic Stroke). - Cross organizational collaboration with R&D to design phase IIIB and IV clinical study programmes.- Optimize global sales of established products:Ebixa (Alzhiemers), Azilect (Parkinson) - joint venture with Teva Pharmaceuticals, Circadin (Sleep) RESULTS:- Signifincant sales growth of Cipralex/Lexapro, Ebixa, Azilect, reported by IMS Global sales data. - Define strategic direction and launch platform for Brintellix- In licensing and commercial launch of Sycrets/Saphris. - Establish new Corporate Payer and Market Access department. - Establish Medical Affairs division.

Copenhagen Area, Capital Region, Denmark

RESPONSIBILITIES- Head of Strategic Marketing Established Products- Responsible for optimising global sales and profits of Cipralex, Lexapro (USA), Ebixa, Azilect, Circadin. - 40 employees in own organisation; 4 product/brand teams, 1 congress and 1 sales excellence team, cross organisational project management from R&D, Regulatory, Patent, Finance, Supply, etc. RESULTS- Cipralex/Lexapro obtained value market leadership with more than 3 billion USD global sales (Launched 2002) - Significant sales growth of Cipralex/Lexapro, Ebixa and Azilect reported by IMS Global Sales. - Launch of "I CAN" - internet based patient compliance system.

Copenhagen Area, Capital Region, Denmark

RESPONSIBILITIES- Team Leader for Cipralex/Lexapro global marketing. - Objective: Optimise Cipralex/Lexapro global sales and profits via defining, communicating, implementing global commercial strategies, tactics and life cycle management. - Cross organisational collaboration in headquarter and in country affiliates to ensure speed and maximum effect of defined commercial strategies and tactics. RESULTS- Significant sales growth of Cipralex/Lexapro, reported by IMS Global Sales. - International launch of the "Allosteric mechanism" campaign for Cipralex. - Developed international research field with allosteric pharmacology to support the communication of Cipralex unique mode of pharmacological action. - Established lean process for execution of congress and event planning and implementation.

Copenhagen Area, Capital Region, Denmark

RESPONSIBILITIES- Senior Project Director for Cipralex/Lexapro in R&D Project Management organisation.- Teamleader for cross organisational teams (Clinical Research, Regulatory, Patent, Sales, Marketing, Supply, SMC, Finance, Business Development). - Reported directly to H. Lundbeck CEO, Claus Bræstrup. - Optimise Cipralex/Lexapro global long term sales and profit via developing and implementing life cycle management strategies and tactics. RESULTS- European Regulatory agencies approval of Cipralex/Lexapro allosteric mechanism of action, which explains Cipralex faster and strong efficacy; major competitive advantage => estimated to have increased Cipralex/Lexapro European and International markets peak sales by 35-40%. - First Cipralex patent court case and establishment of European lawyer network prepared to defend a potential patent infringement of Cipralex. - Decide, develop and launch new drops formulation for the Italian market; - 35% of sales within N6A in Italy is drops formulations.

Copenhagen Area, Capital Region, Denmark

RESPONSIBILITIES- Director for Business Development (Geographic) and Alliance Management- Develop strategic recommendations to H. Lundbeck A/S management group for where and how to expand Lundbeck geographic reach. - Responsible for optimising Lundbeck partnerships; Forest Laboratories (Lexapro), Merz (Ebixa), Teva (Azilect), Cephalon (CEP 1347). - Evaluate new business opportunities and provide recommendations to Lundbeck management group. RESULTS- Negotiate, close and implement Gaboxadol (sleep) partnership agreement with Merck Sharp Dome (MSD), USA. (In collaboration with head of Corporate Business Development Ole Vahlgren). - The Gaboxadol partnership agreement was the biggest in Lundbeck history; 400 mil. DKK in down payment and milestone payments of 1.200 mil. DKK, as well as strategic and tactical entry to the USA market for Lundbeck. - Develop Lundbeck USA strategy and implementation plan for own Lundbeck sales and marketing organisation in the USA (Greenfield or Acquisition)- Identify, evaluate and negotiate with several USA acquisition candidates.

Copenhagen Area, Capital Region, Denmark

RESPONSIBILITIES- Business development manager with responsibility for Lundbeck geographic expansion on the American continent (Latin America and USA). - Evaluate new markets and new product opportunities to accelerate growth. Provide recommendation to SVP and Lundbeck Corporate management group. - Close collaboration with Lundbeck Regional SVP Americas, Ole Chrintz. RESULTS- Instrumental in analysing, defining strategy, implementing and establishing Lundbeck in Brazil, Argentina and Chile. - Co-promotion partnership agreement with Abbott Laboratories to launch Lexapro in all Latin American markets March 2003. - Instrumental in analysing, defining and recommending the strategy for how to establish Lundbeck in the USA. Amongst other things search, evaluation and negotiate with USA specialty company.

Copenhagen Area, Denmark

 Training of 15 inexperienced combat soldiers  Management and training exercises with this combat group Guarding the Danish Queen – management of the guards.

Master Of Science / Cand. Merc., International Marketing And Strategy

Executive Management Programme, Aligning Strategy And Sales

3 Years Talent Programme For Potential Senior Management Position

12 internal candidates nominated to participate in 3 year programme for potential Senior Management positions

Executive Management, Lausanne, Switzerland., Personal Leadership

Personal Leadership Training

Leadership training. 360 degree evaluation, areas for further development and personal coaching.

Different Management And Leadership Training Prorgrames,

Mini Mba - Managing Medical Product Innovation

1 Semester In Mba Programme As Part Of Cand.Merc., Marketing, Innovation, Strategy, Entrepreneurship

Sergeant

1992 - 1994: Royal Danish Guards (Livgarden) Copenhagen Sergeant  Training of 15 inexperienced combat soldiers  Management and training.